Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs Trade Desk Inc (TTD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs Trade Desk Inc — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.98 (market cap $25.27B), while Trade Desk Inc trades at $12.09 (market cap $5.83B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 4.3× Trade Desk Inc's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Trade Desk Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 1 Days and Trade Desk Inc for 72 Days on average.
| RPRX | TTD | |
|---|---|---|
Market Cap | $25.27B | $5.83B |
Volume | 3,671,183 | 15,864,392 |
Sector | Health | Media |
52-Week High | $63.96 | $54.13 |
52-Week Low | $35.44 | $11.92 |
Typical Hold Time | 1 Days | 72 Days |
Enterprise Value | $32.50B | $4.78B |
Dividend Yield | 1.66% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
The Trade Desk (TTD) trades at $12.08, down 0.12% on the day and showing bearish technical signals with mixed earnings performance. The company maintains strong profitability with 76.9% gross margins and 15.4% ROE, though revenue growth has slowed to 3% in 2026 projections. Recent news highlights competitive pressures from Amazon and Alphabet, with the stock down significantly from its 2024 peak.
While TTD's valuation appears attractive with low P/E and P/S ratios, investors face headwinds from slowing growth and intense competition. The consensus price target of $14.72 suggests moderate upside potential, but near-term catalysts appear limited as the company navigates market share challenges and workforce reductions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About Trade Desk Inc
The Trade Desk Inc is engaged in providing a technology platform for ad buyers. Through its cloud-based platform ad buyers can create, manage, and optimize data-driven digital advertising campaigns across ad formats and channels, including display, video, audio, in-app, native and social, on a multitude of devices. Its products include Data Management Platform, Cross-Device Targeting, Video Advertising, Mobile Advertising, and others.
Read more on TTD →
